UBS Group
SGYP

UBS Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

UBS Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-45,000
Closed -$77K – 8558
2018
Q3 		$77K Buy
45,000
+2,500
+6% +$4.47K ﹤0.01% 5815
2018
Q2 		$74K Buy
+42,500
New +$73.5K ﹤0.01% 5678

Other funds holding SGYP

TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return